Publisher
Springer Science and Business Media LLC
Reference41 articles.
1. Vigneswaran N, Williams M. Epidemiologic trends in head and neck cancer and aids in diagnosis. Oral Maxillofac Surg Clin North Am. 2014;26(2):123–41.
2. Macmillan Cancer Support. Rich Picture. People with head and neck cancer. 2014 Contract No.: MAC13845_11_14.
3. Cancer incidence projections for Scotland 2013-2017 publication report. Information Services Division, NHS National Services Scotland; 2015.
4. van der Molen L, van Rossum MA, Burkhead LM, Smeele LE, Hilgers FJ. Functional outcomes and rehabilitation strategies in patients treated with chemoradiotherapy for advanced head and neck cancer: a systematic review. Eur Arch Otorhinolaryngol. 2009;266(6):889–900. Epub 2008/10/01.
5. Russi EG, Corvo R, Merlotti A, Alterio D, Franco P, Pergolizzi S, et al. Swallowing dysfunction in head and neck cancer patients treated by radiotherapy: review and recommendations of the supportive task group of the Italian Association of Radiation Oncology. Cancer Treat Rev. 2012;38(8):1033–49.
Cited by
10 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Dysphagia Advances in Head and Neck Cancer;Current Otorhinolaryngology Reports;2023-02-15
2. New phthalimide-based derivatives as EGFR-TK inhibitors: Synthesis, biological evaluation, and molecular modeling study;Bioorganic Chemistry;2022-10
3. Prehabilitation in head and neck cancer patients: a literature review;Journal of Otolaryngology - Head & Neck Surgery;2021-01-06
4. Design, synthesis and biological evaluation of new series of hexahydroquinoline and fused quinoline derivatives as potent inhibitors of wild-type EGFR and mutant EGFR (L858R and T790M);Bioorganic Chemistry;2020-12
5. 1,4,5,6,7,8-Hexahydroquinolines and 5,6,7,8-tetrahydronaphthalenes: A new class of antitumor agents targeting the colchicine binding site of tubulin;Bioorganic Chemistry;2020-06